Live Analyst Rating Changes 4942 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/William Bonello
C-H
William Bonello
Wall Street Analyst
★★★★☆
#590
on 13Foresight · ranked by our own returns
64%
Success Rate
+23.6%
Average Return
30 of 47 calls profitable · +13.2% vs benchmark
📈 Across the calls we could measure, roughly 64% of William Bonello's ratings turned a profit when each position was held for 1 year — averaging +23.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

148 Buy 11 Hold 0 Sell
William's Stock Coverage 46 ratings · 2026-07-04
Company Date Position Consensus Price Target 1-Yr Return
SRTA
Strata Critical Medical
Jun 26, 2026 BUY Strong Buy
+30.8% avg upside
11 analysts
·
CDNA
CareDx
Jun 25, 2026 HOLD Buy
+12.2% avg upside
16 analysts
+4.8%
NTRA
Natera
Jun 24, 2026 BUY Strong Buy
-8.7% avg upside
26 analysts
+7.4%
NEO
NeoGenomics
Jun 17, 2026 BUY Strong Buy
+0.8% avg upside
17 analysts
+46.1%
WGS
GeneDx Holdings
Jun 09, 2026 BUY Strong Buy
+7.0% avg upside
9 analysts
+19.9%
SOPH
SOPHiA GENETICS
Jun 08, 2026 BUY Strong Buy
+79.5% avg upside
7 analysts
·
SERA
Sera Prognostics
Jun 04, 2026 BUY Strong Buy
+272.5% avg upside
7 analysts
$6.00
200.02% Upside
-19.8%
VCYT
Veracyte
May 22, 2026 BUY Strong Buy
-22.6% avg upside
17 analysts
·
PSNL
Personalis
May 20, 2026 BUY Strong Buy
-12.7% avg upside
11 analysts
+71.3%
MDXH
MDxHealth
May 14, 2026 BUY Strong Buy
+1233.5% avg upside
8 analysts
$3.00
529.54% Upside
-51.6%
MYGN
Myriad Genetics
May 06, 2026 BUY Hold
+213.2% avg upside
24 analysts
$10.00
67.00% Upside
-4.9%
ADPT
Adaptive Biotechnologies
May 05, 2026 BUY Strong Buy
-0.5% avg upside
14 analysts
+53.8%
BDSX
Biodesix
May 05, 2026 BUY Strong Buy
+47.1% avg upside
8 analysts
-0.9%
QDEL
QuidelOrtho
May 05, 2026 BUY Buy
+112.9% avg upside
13 analysts
+18.3%
CERS
Cerus
May 01, 2026 BUY Strong Buy
+70.1% avg upside
10 analysts
+3.7%
XGN
Exagen
Mar 11, 2026 BUY Strong Buy
+159.4% avg upside
10 analysts
$10.00
120.24% Upside
+17.0%
GH
Guardant Health
Feb 20, 2026 BUY Strong Buy
-21.0% avg upside
30 analysts
$125.00
25.51% Downside
+62.9%
LUNR
Intuitive Machines
Oct 29, 2025 BUY Strong Buy
+83.2% avg upside
15 analysts
+68.0%
CERT
Certara
Oct 23, 2025 BUY Buy
+85.6% avg upside
21 analysts
-44.2%
BTBT
Bit Digital
Aug 18, 2025 BUY Strong Buy
+198.0% avg upside
7 analysts
$5.00
203.13% Upside
-50.7%
SIMO
Silicon Motion
Jun 27, 2025 BUY Strong Buy
-29.5% avg upside
19 analysts
+310.3%
HROW
Harrow Health
Jun 25, 2025 BUY Strong Buy
+25.5% avg upside
12 analysts
+31.5%
MGNI
Magnite
May 05, 2025 BUY Strong Buy
+10.5% avg upside
27 analysts
+11.8%
WT
WisdomTree
Mar 10, 2025 BUY Buy
-24.7% avg upside
19 analysts
+97.0%
AIRG
Airgain
Feb 21, 2025 BUY Strong Buy
+14.4% avg upside
8 analysts
-21.6%
NVTS
Navitas Semiconductor
Feb 19, 2025 BUY Buy
-4.4% avg upside
14 analysts
+134.9%
RGEN
Repligen
Feb 12, 2025 BUY Strong Buy
+19.2% avg upside
25 analysts
-9.0%
DKNG
DraftKings
Feb 10, 2025 BUY Strong Buy
+45.0% avg upside
51 analysts
-36.7%
ALAB
Astera Labs, Inc.
Feb 06, 2025 BUY Strong Buy
-31.5% avg upside
24 analysts
+62.5%
PRLB
Proto Labs
Feb 04, 2025 HOLD Buy
-7.4% avg upside
11 analysts
+24.0%
GPRE
Green Plains
Jan 31, 2025 BUY Buy
+1.2% avg upside
14 analysts
+28.3%
PAR
Par Technology
Jan 21, 2025 BUY Strong Buy
+66.8% avg upside
14 analysts
-54.4%
DCTH
Delcath Systems
Jan 17, 2025 BUY Strong Buy
+61.9% avg upside
11 analysts
$21.00
59.04% Upside
-27.5%
LCTX
Lineage Therap
Nov 15, 2024 BUY Strong Buy
+296.9% avg upside
16 analysts
$4.00
196.38% Upside
+118.6%
MYO
Myomo
Sep 18, 2024 BUY Strong Buy
+608.7% avg upside
9 analysts
-77.9%
CSBR
Champions Oncology
Sep 12, 2024 BUY Strong Buy
+47.6% avg upside
6 analysts
$6.00
4.18% Upside
+53.1%
OUST
Ouster
Aug 20, 2024 BUY Strong Buy
-18.7% avg upside
14 analysts
+277.0%
PLUG
Plug Power
Jul 09, 2024 BUY Buy
+259.9% avg upside
45 analysts
-30.7%
SWBI
Smith & Wesson Brands
Jun 20, 2024 BUY Buy
+30.5% avg upside
11 analysts
-44.3%
EHC
Encompass Health
Feb 13, 2017 BUY Strong Buy
+4.4% avg upside
22 analysts
$48.00
54.82% Downside
+29.2%
RDNT
Radnet
Nov 09, 2016 HOLD Strong Buy
+16.7% avg upside
10 analysts
·
TRIB
Trinity Biotech
Oct 23, 2015 HOLD Hold
1 analyst
-40.9%
OPCH
Option Care Health
Apr 09, 2015 BUY Strong Buy
+35.2% avg upside
20 analysts
$7.00
68.00% Downside
-56.6%
RIOT
Riot Platforms
Jan 29, 2015 HOLD Strong Buy
+28.4% avg upside
28 analysts
·
DGX
Quest Diagnostics
Sep 19, 2013 BUY Buy
-20.8% avg upside
33 analysts
$74.00
65.70% Downside
+4.8%
LH
Labcorp Holdings
Aug 28, 2013 BUY Strong Buy
-9.2% avg upside
36 analysts
$116.00
59.48% Downside
+9.7%
🔒 41 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
William Bonello — Frequently Asked Questions
How accurate are William Bonello's stock ratings?
Based on the calls 13Foresight could measure, about 64% of William's ratings were profitable over a one-year hold, with an average return of +23.6% per rating, or +13.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is William ranked on 13Foresight?
William Bonello is currently ranked #590 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does William cover?
William most recently has ratings on SRTA, CDNA, NTRA, NEO, WGS, SOPH, SERA, VCYT, PSNL, MDXH, MYGN, ADPT and 34 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.